Live Breaking News & Updates on Gilead Life Sciences|Page 4
Stay updated with breaking news from Gilead life sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DUBLIN (BUSINESS WIRE) The "Antibody Drug Conjugates Market Size, Share & Trends Analysis Report by Application (Blood Cancer, Breast Cancer, Urothelial/Bladder Cancer), by Technology (Cleavable, Non-cleavable Linker, Linkerless), and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's. ....
Cystic Fibrosis Therapeutics Market revenue to cross USD 26.6 Bn by 2027: Global Market Insights Inc. forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
Centre places export of Remdesivir, API in 'restricted' category businesstoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstoday.in Daily Mail and Mail on Sunday newspapers.
Remdesivir output jumps 10 times, govt halts central allocation to states By IANS | 0 Views Remdesivir output jumps 10 times, govt halts central allocation to states. Image Source: IANS News New Delhi, May 29 : As the production of Remdesivir was ramped up ten times from 33,000 vials per day to 3.5 lakh, the Central government on Saturday decided to discontinue the central allocation of Remdesivir vials to states. Minister of State for Chemicals and Fertilisers, Mansukh Mandaviya, made the announcement and also directed the National Pharmaceuticals Pricing Agency and Central Drugs Standard Control Organisation (CDSCO) to continuously monitor the availability of Remdesivir in the country. The Minister informed that the production of Remdesivir was ramped up ten times from 33,000 vials per day on April 11 this year to 3,50,000 vials per day on Saturday. ....
Just as India s drug manufacturers and pharma businesses are catching up with demands for anti-viral drug Remdesivir, plans are afoot to remove the drug from the list. ....